User:Michael Fischbach: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
(20 intermediate revisions by the same user not shown)
Line 2: Line 2:
[[Image:MAF.jpg|thumb|right|Michael Fischbach]]
[[Image:MAF.jpg|thumb|right|Michael Fischbach]]


*Michael Fischbach
*Department of Bioengineering and Therapeutic Sciences
*Department of Molecular Biology
*UCSF, Byers Hall 308C
*Massachusetts General Hospital
*1700 4th Street
*Simches Research Center
*San Francisco, CA 94158-2330
*185 Cambridge Street
 
*Boston, MA 02114
*Email: fischbach [at] fischbachgroup [dot] org
*[[Special:Emailuser/Michael Fischbach|Email me through OpenWetWare]]
*[[Special:Emailuser/Michael Fischbach|Email me through OpenWetWare]]


==Education==
==Education==
* 2007, PhD, Harvard University
* 2007, PhD, Harvard University
* 2003, AB, Harvard College
* 2003, AB, Harvard College <span style="text-decoration: overline">D</span>
<span style="font-size:50%">d</span>&#772;</td>


==Publications==
==Publications==
<biblio>
<biblio>


#Paper40 pmid=20441613
#Paper39 pmid=20371346
#Paper38 pmid=20121095
#Paper37 pmid=20041689
#Paper36 pmid=19741609
#Paper35 pmid=19713519
#Paper34 pmid=19695947
#Paper33 pmid=19555023
#Paper33 pmid=19555023
#Paper32 pmid=19515346
#Paper32 pmid=19515346
Line 24: Line 30:
#Paper29 pmid=19114652
#Paper29 pmid=19114652
#Paper28 pmid=18663394
#Paper28 pmid=18663394
#Paper27 pmid=18403782
#Paper27 pmid=18576462
#Paper26 pmid=18216259
#Paper26 pmid=18403782
#Paper25 pmid=18576462
#Paper25 pmid=18216259
#Paper24 pmid=17973380
#Paper24 pmid=17973380
#Paper23 pmid=17620609
#Paper23 pmid=17620609
Line 32: Line 38:
#Paper21 pmid=17234808
#Paper21 pmid=17234808
#Paper20 pmid=17190806
#Paper20 pmid=17190806
#Paper19 pmid=17160060
#Paper19 pmid=17163637
#Paper18 pmid=17060628
#Paper18 pmid=17160060
#Paper17 pmid=17068249
#Paper17 pmid=17068249
#Paper16 pmid=16925399
#Paper16 pmid=17060628
#Paper15 pmid=16922493
#Paper15 pmid=16925399
#Paper14 pmid=16910643
#Paper14 pmid=16922493
#Paper13 pmid=16895337
#Paper13 pmid=16910643
#Paper12 pmid=16848455
#Paper12 pmid=16895337
#Paper11 pmid=16857816
#Paper11 pmid=16857816
#Paper10 pmid=16567620
#Paper10 pmid=16848455
#Paper9 pmid=16485005
#Paper9 pmid=16757312
#Paper8 pmid=17163637
#Paper8 pmid=16567620
#Paper7 pmid=16460000
#Paper7 pmid=16485005
#Paper6 pmid=16450029
#Paper6 pmid=16460000
#Paper5 pmid=16757312
#Paper5 pmid=16450029
#Paper4 pmid=16076215
#Paper4 pmid=16076215
#Paper3 pmid=15598734
#Paper3 pmid=15598734
#Paper2 pmid=15314232
#Paper2 pmid=15314232
#Paper1 pmid=12874011
#Paper1 pmid=12874011


</biblio>
</biblio>

Latest revision as of 22:48, 5 November 2010

Contact Info

Michael Fischbach
  • Department of Bioengineering and Therapeutic Sciences
  • UCSF, Byers Hall 308C
  • 1700 4th Street
  • San Francisco, CA 94158-2330

Education

  • 2007, PhD, Harvard University
  • 2003, AB, Harvard College D

d̄

Publications

  1. Fischbach MA and Krogan NJ. The next frontier of systems biology: higher-order and interspecies interactions. Genome Biol. 2010;11(5):208. DOI:10.1186/gb-2010-11-5-208 | PubMed ID:20441613 | HubMed [Paper40]
  2. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M, and Settleman J. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010 Apr 2;141(1):69-80. DOI:10.1016/j.cell.2010.02.027 | PubMed ID:20371346 | HubMed [Paper39]
  3. Walsh CT and Fischbach MA. Natural products version 2.0: connecting genes to molecules. J Am Chem Soc. 2010 Mar 3;132(8):2469-93. DOI:10.1021/ja909118a | PubMed ID:20121095 | HubMed [Paper38]
  4. Dawlaty J, Zhang X, Fischbach MA, and Clardy J. Dapdiamides, tripeptide antibiotics formed by unconventional amide ligases. J Nat Prod. 2010 Mar 26;73(3):441-6. DOI:10.1021/np900685z | PubMed ID:20041689 | HubMed [Paper37]
  5. Haas BJ, Kamoun S, Zody MC, Jiang RH, Handsaker RE, Cano LM, Grabherr M, Kodira CD, Raffaele S, Torto-Alalibo T, Bozkurt TO, Ah-Fong AM, Alvarado L, Anderson VL, Armstrong MR, Avrova A, Baxter L, Beynon J, Boevink PC, Bollmann SR, Bos JI, Bulone V, Cai G, Cakir C, Carrington JC, Chawner M, Conti L, Costanzo S, Ewan R, Fahlgren N, Fischbach MA, Fugelstad J, Gilroy EM, Gnerre S, Green PJ, Grenville-Briggs LJ, Griffith J, Grünwald NJ, Horn K, Horner NR, Hu CH, Huitema E, Jeong DH, Jones AM, Jones JD, Jones RW, Karlsson EK, Kunjeti SG, Lamour K, Liu Z, Ma L, Maclean D, Chibucos MC, McDonald H, McWalters J, Meijer HJ, Morgan W, Morris PF, Munro CA, O'Neill K, Ospina-Giraldo M, Pinzón A, Pritchard L, Ramsahoye B, Ren Q, Restrepo S, Roy S, Sadanandom A, Savidor A, Schornack S, Schwartz DC, Schumann UD, Schwessinger B, Seyer L, Sharpe T, Silvar C, Song J, Studholme DJ, Sykes S, Thines M, van de Vondervoort PJ, Phuntumart V, Wawra S, Weide R, Win J, Young C, Zhou S, Fry W, Meyers BC, van West P, Ristaino J, Govers F, Birch PR, Whisson SC, Judelson HS, and Nusbaum C. Genome sequence and analysis of the Irish potato famine pathogen Phytophthora infestans. Nature. 2009 Sep 17;461(7262):393-8. DOI:10.1038/nature08358 | PubMed ID:19741609 | HubMed [Paper36]
  6. Fischbach MA and Walsh CT. Antibiotics for emerging pathogens. Science. 2009 Aug 28;325(5944):1089-93. DOI:10.1126/science.1176667 | PubMed ID:19713519 | HubMed [Paper35]
  7. Fischbach MA. Antibiotics from microbes: converging to kill. Curr Opin Microbiol. 2009 Oct;12(5):520-7. DOI:10.1016/j.mib.2009.07.002 | PubMed ID:19695947 | HubMed [Paper34]
  8. Walsh CT and Fischbach MA. New ways to squash superbugs. Sci Am. 2009 Jul;301(1):44-51. DOI:10.1038/scientificamerican0709-44 | PubMed ID:19555023 | HubMed [Paper33]
  9. Clardy J, Fischbach MA, and Currie CR. The natural history of antibiotics. Curr Biol. 2009 Jun 9;19(11):R437-41. DOI:10.1016/j.cub.2009.04.001 | PubMed ID:19515346 | HubMed [Paper32]
  10. Wieland Brown LC, Acker MG, Clardy J, Walsh CT, and Fischbach MA. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2549-53. DOI:10.1073/pnas.0900008106 | PubMed ID:19196969 | HubMed [Paper31]
  11. Walsh CT and Fischbach MA. Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1689-90. DOI:10.1073/pnas.0813405106 | PubMed ID:19193851 | HubMed [Paper30]
  12. López D, Fischbach MA, Chu F, Losick R, and Kolter R. Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):280-5. DOI:10.1073/pnas.0810940106 | PubMed ID:19114652 | HubMed [Paper29]
  13. Sattely ES, Fischbach MA, and Walsh CT. Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Nat Prod Rep. 2008 Aug;25(4):757-93. DOI:10.1039/b801747f | PubMed ID:18663394 | HubMed [Paper28]
  14. Walsh CT and Fischbach MA. Inhibitors of sterol biosynthesis as Staphylococcus aureus antibiotics. Angew Chem Int Ed Engl. 2008;47(31):5700-2. DOI:10.1002/anie.200801801 | PubMed ID:18576462 | HubMed [Paper27]
  15. Stinear TP, Seemann T, Harrison PF, Jenkin GA, Davies JK, Johnson PD, Abdellah Z, Arrowsmith C, Chillingworth T, Churcher C, Clarke K, Cronin A, Davis P, Goodhead I, Holroyd N, Jagels K, Lord A, Moule S, Mungall K, Norbertczak H, Quail MA, Rabbinowitsch E, Walker D, White B, Whitehead S, Small PL, Brosch R, Ramakrishnan L, Fischbach MA, Parkhill J, and Cole ST. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 2008 May;18(5):729-41. DOI:10.1101/gr.075069.107 | PubMed ID:18403782 | HubMed [Paper26]
  16. Fischbach MA, Walsh CT, and Clardy J. The evolution of gene collectives: How natural selection drives chemical innovation. Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4601-8. DOI:10.1073/pnas.0709132105 | PubMed ID:18216259 | HubMed [Paper25]
  17. Nolan EM, Fischbach MA, Koglin A, and Walsh CT. Biosynthetic tailoring of microcin E492m: post-translational modification affords an antibacterial siderophore-peptide conjugate. J Am Chem Soc. 2007 Nov 21;129(46):14336-47. DOI:10.1021/ja074650f | PubMed ID:17973380 | HubMed [Paper24]
  18. Fischbach MA, Lai JR, Roche ED, Walsh CT, and Liu DR. Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11951-6. DOI:10.1073/pnas.0705348104 | PubMed ID:17620609 | HubMed [Paper23]
  19. Fischbach MA and Clardy J. One pathway, many products. Nat Chem Biol. 2007 Jul;3(7):353-5. DOI:10.1038/nchembio0707-353 | PubMed ID:17576415 | HubMed [Paper22]
  20. Butcher RA, Schroeder FC, Fischbach MA, Straight PD, Kolter R, Walsh CT, and Clardy J. The identification of bacillaene, the product of the PksX megacomplex in Bacillus subtilis. Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1506-9. DOI:10.1073/pnas.0610503104 | PubMed ID:17234808 | HubMed [Paper21]
  21. Straight PD, Fischbach MA, Walsh CT, Rudner DZ, and Kolter R. A singular enzymatic megacomplex from Bacillus subtilis. Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):305-10. DOI:10.1073/pnas.0609073103 | PubMed ID:17190806 | HubMed [Paper20]
  22. Luo M, Lin H, Fischbach MA, Liu DR, Walsh CT, and Groves JT. Enzymatic tailoring of enterobactin alters membrane partitioning and iron acquisition. ACS Chem Biol. 2006 Feb 17;1(1):29-32. DOI:10.1021/cb0500034 | PubMed ID:17163637 | HubMed [Paper19]
  23. Clardy J, Fischbach MA, and Walsh CT. New antibiotics from bacterial natural products. Nat Biotechnol. 2006 Dec;24(12):1541-50. DOI:10.1038/nbt1266 | PubMed ID:17160060 | HubMed [Paper18]
  24. Fischbach MA and Walsh CT. Biochemistry. Directing biosynthesis. Science. 2006 Oct 27;314(5799):603-5. DOI:10.1126/science.1132692 | PubMed ID:17068249 | HubMed [Paper17]
  25. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, and Smith KD. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7. DOI:10.1073/pnas.0604636103 | PubMed ID:17060628 | HubMed [Paper16]
  26. Lai JR, Fischbach MA, Liu DR, and Walsh CT. Localized protein interaction surfaces on the EntB carrier protein revealed by combinatorial mutagenesis and selection. J Am Chem Soc. 2006 Aug 30;128(34):11002-3. DOI:10.1021/ja063238h | PubMed ID:16925399 | HubMed [Paper15]
  27. Larsen NA, Lin H, Wei R, Fischbach MA, and Walsh CT. Structural characterization of enterobactin hydrolase IroE. Biochemistry. 2006 Aug 29;45(34):10184-90. DOI:10.1021/bi060950i | PubMed ID:16922493 | HubMed [Paper14]
  28. Jin M, Fischbach MA, and Clardy J. A biosynthetic gene cluster for the acetyl-CoA carboxylase inhibitor andrimid. J Am Chem Soc. 2006 Aug 23;128(33):10660-1. DOI:10.1021/ja063194c | PubMed ID:16910643 | HubMed [Paper13]
  29. Fischbach MA and Walsh CT. Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. Chem Rev. 2006 Aug;106(8):3468-96. DOI:10.1021/cr0503097 | PubMed ID:16895337 | HubMed [Paper12]
  30. Sharma SV, Fischbach MA, Haber DA, and Settleman J. "Oncogenic shock": explaining oncogene addiction through differential signal attenuation. Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4392s-4395s. DOI:10.1158/1078-0432.CCR-06-0096 | PubMed ID:16857816 | HubMed [Paper11]
  31. Lin H, Fischbach MA, Gatto GJ Jr, Liu DR, and Walsh CT. Bromoenterobactins as potent inhibitors of a pathogen-associated, siderophore-modifying C-glycosyltransferase. J Am Chem Soc. 2006 Jul 26;128(29):9324-5. DOI:10.1021/ja063236x | PubMed ID:16848455 | HubMed [Paper10]
  32. Fischbach MA and Settleman J. Regulation of the nucleotide state of oncogenic ras proteins by nucleoside diphosphate kinase. Methods Enzymol. 2006;407:33-45. DOI:10.1016/S0076-6879(05)07004-7 | PubMed ID:16757312 | HubMed [Paper9]
  33. Lai JR, Fischbach MA, Liu DR, and Walsh CT. A protein interaction surface in nonribosomal peptide synthesis mapped by combinatorial mutagenesis and selection. Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5314-9. DOI:10.1073/pnas.0601038103 | PubMed ID:16567620 | HubMed [Paper8]
  34. Fischbach MA, Lin H, Liu DR, and Walsh CT. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol. 2006 Mar;2(3):132-8. DOI:10.1038/nchembio771 | PubMed ID:16485005 | HubMed [Paper7]
  35. Dorrestein PC, Blackhall J, Straight PD, Fischbach MA, Garneau-Tsodikova S, Edwards DJ, McLaughlin S, Lin M, Gerwick WH, Kolter R, Walsh CT, and Kelleher NL. Activity screening of carrier domains within nonribosomal peptide synthetases using complex substrate mixtures and large molecule mass spectrometry. Biochemistry. 2006 Feb 14;45(6):1537-46. DOI:10.1021/bi052333k | PubMed ID:16460000 | HubMed [Paper6]
  36. Garstecki P, J Fuerstman M, Fischbach MA, Sia SK, and Whitesides GM. Mixing with bubbles: a practical technology for use with portable microfluidic devices. Lab Chip. 2006 Feb;6(2):207-12. DOI:10.1039/b510843h | PubMed ID:16450029 | HubMed [Paper5]
  37. Lin H, Fischbach MA, Liu DR, and Walsh CT. In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes. J Am Chem Soc. 2005 Aug 10;127(31):11075-84. DOI:10.1021/ja0522027 | PubMed ID:16076215 | HubMed [Paper4]
  38. Fischbach MA, Lin H, Liu DR, and Walsh CT. In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):571-6. DOI:10.1073/pnas.0408463102 | PubMed ID:15598734 | HubMed [Paper3]
  39. Wolfe DB, Conroy RS, Garstecki P, Mayers BT, Fischbach MA, Paul KE, Prentiss M, and Whitesides GM. Dynamic control of liquid-core/liquid-cladding optical waveguides. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12434-8. DOI:10.1073/pnas.0404423101 | PubMed ID:15314232 | HubMed [Paper2]
  40. Fischbach MA and Settleman J. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase. Cancer Res. 2003 Jul 15;63(14):4089-94. PubMed ID:12874011 | HubMed [Paper1]

All Medline abstracts: PubMed | HubMed

Useful links